Revenue guidance for Q4:
Y-axis: AUD millions
X-axis: calendar year quarters (ie 2023 Q2 = FYQ4)
Blue column= revenue projection
Purple column= reported revenue
Revenue guidance for FY23 Q4 is AU$204 million, some $54million above UBS estimates. How an analyst firm can get estimates so wrong is beyond me.. If in the ballpark, then this points to a significant upside surprise (Monday).
Important note: over a full year, my guidance is generally spot on, while there can be significant errors during shorter timeframes (e.g. months/quarters - as you can see in the graph). But, numbers are real, not made up, differences are predominantly due to timing of reporting.
DYOR
- Forums
- ASX - By Stock
- LYC
- Deciphering Lynas
LYC
lynas rare earths limited
Add to My Watchlist
3.48%
!
$8.88

Deciphering Lynas, page-660
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.88 |
Change
-0.320(3.48%) |
Mkt cap ! $8.306B |
Open | High | Low | Value | Volume |
$9.44 | $9.44 | $8.86 | $61.13M | 6.800M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 225 | $8.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.91 | 24100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 8.880 |
1 | 80 | 8.850 |
1 | 508 | 8.830 |
1 | 675 | 8.820 |
6 | 3145 | 8.800 |
Price($) | Vol. | No. |
---|---|---|
8.930 | 200 | 1 |
8.950 | 200 | 1 |
8.960 | 650 | 1 |
8.990 | 164 | 1 |
9.020 | 1100 | 1 |
Last trade - 16.11pm 27/06/2025 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online